Glioblastoma multiforme (GBM) research is on the cusp of genetic and molecular discoveries that will forever alter current diagnostic, prognostic, and therapeutic achievements. A highly aggressive and complex brain tumor type, GBM tumors are also one of the most devastating forms of cancer, affecting thousands of Americans each day.
To address this growing need, the National Brain Tumor Society in 2013 launched the Defeat GBM Research Collaborative, a multifaceted and concentrated research-based effort, which aims to double the five-year survival rate of GBM patients – in just five years. The Initiative will drive the advancement of this therapeutic development area to better understand how to combat its resistance and adaptability, and deliver new and effective treatments to improve patient survival.
Click on the photos below to learn more about the Defeat GBM Research Collaborative.